<!DOCTYPE html>
<html lang="en" dir="ltr">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="manifest" href="/manifest.json">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">

  <!-- SEO -->
  <title>Bile Duct Cancer (Cholangiocarcinoma) ‚Äî Comprehensive Guide | StopMyCancer</title>
  <meta name="description" content="Comprehensive, evidence-based bile duct cancer guide. Types, risk factors, staging, treatment options including surgery, chemotherapy, and targeted therapy. Explained without jargon.">
  <meta name="keywords" content="bile duct cancer, cholangiocarcinoma, intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, biliary cancer, bile duct cancer symptoms, bile duct cancer staging, bile duct cancer treatment, biliary stent, gemcitabine, cisplatin">
  <meta name="author" content="StopMyCancer">
  <link rel="canonical" href="https://stopmycancer.com/cancers/bile-duct/">
  <meta name="robots" content="index, follow">

  <!-- Open Graph -->
  <meta property="og:type" content="article">
  <meta property="og:title" content="Bile Duct Cancer (Cholangiocarcinoma) ‚Äî Comprehensive Guide | StopMyCancer">
  <meta property="og:description" content="Plain-language, evidence-based bile duct cancer guide. Types, risk factors, staging, diagnosis, treatment, and questions to ask your doctor.">
  <meta property="og:url" content="https://stopmycancer.com/cancers/bile-duct/">
  <meta property="og:site_name" content="StopMyCancer">
  <meta property="og:locale" content="en_US">
  <meta property="og:locale:alternate" content="es_ES">
  <meta property="og:locale:alternate" content="fr_FR">
  <meta property="og:image" content="https://images.unsplash.com/photo-1576091160550-2173dba999ef?w=1200&h=630&fit=crop&q=80">

  <!-- Twitter Card -->
  <meta name="twitter:card" content="summary_large_image">
  <meta name="twitter:title" content="Bile Duct Cancer (Cholangiocarcinoma) ‚Äî Comprehensive Guide | StopMyCancer">
  <meta name="twitter:description" content="Plain-language, evidence-based bile duct cancer guide. Types, risk factors, staging, treatment, and questions to ask your doctor.">
  <meta name="twitter:image" content="https://images.unsplash.com/photo-1576091160550-2173dba999ef?w=1200&h=630&fit=crop&q=80">

  <!-- Structured Data ‚Äî MedicalCondition -->
  <script type="application/ld+json">
  {
    "@context": "https://schema.org",
    "@type": "MedicalCondition",
    "name": "Bile Duct Cancer",
    "alternateName": ["Cholangiocarcinoma", "Biliary Cancer", "Bile Duct Carcinoma"],
    "description": "Bile duct cancer, also known as cholangiocarcinoma, is a rare cancer that develops in the cells of the bile ducts ‚Äî the tubes that carry bile from the liver to the small intestine. It can originate inside the liver (intrahepatic) or outside the liver (extrahepatic).",
    "url": "https://stopmycancer.com/cancers/bile-duct/",
    "code": {
      "@type": "MedicalCode",
      "codeValue": "C24.0",
      "codingSystem": "ICD-10"
    },
    "associatedAnatomy": {
      "@type": "AnatomicalStructure",
      "name": "Bile Duct"
    },
    "riskFactor": [
      {"@type": "MedicalRiskFactor", "name": "Primary sclerosing cholangitis (PSC)"},
      {"@type": "MedicalRiskFactor", "name": "Chronic biliary tract infection"},
      {"@type": "MedicalRiskFactor", "name": "Cirrhosis"},
      {"@type": "MedicalRiskFactor", "name": "Choledochal cysts"},
      {"@type": "MedicalRiskFactor", "name": "Liver fluke infection"},
      {"@type": "MedicalRiskFactor", "name": "Age over 50"},
      {"@type": "MedicalRiskFactor", "name": "Inflammatory bowel disease"}
    ],
    "signOrSymptom": [
      {"@type": "MedicalSignOrSymptom", "name": "Jaundice (yellowing of skin and eyes)"},
      {"@type": "MedicalSignOrSymptom", "name": "Itching (pruritus)"},
      {"@type": "MedicalSignOrSymptom", "name": "Abdominal pain"},
      {"@type": "MedicalSignOrSymptom", "name": "Pale-colored stools"},
      {"@type": "MedicalSignOrSymptom", "name": "Dark urine"}
    ],
    "possibleTreatment": [
      {"@type": "MedicalTherapy", "name": "Surgical resection"},
      {"@type": "MedicalTherapy", "name": "Liver transplantation"},
      {"@type": "MedicalTherapy", "name": "Chemotherapy with gemcitabine and cisplatin"},
      {"@type": "MedicalTherapy", "name": "Biliary stent placement"},
      {"@type": "MedicalTherapy", "name": "Targeted therapy"},
      {"@type": "MedicalTherapy", "name": "Radiation therapy"}
    ],
    "typicalTest": [
      {"@type": "MedicalTest", "name": "CT scan"},
      {"@type": "MedicalTest", "name": "MRI and MRCP"},
      {"@type": "MedicalTest", "name": "Liver function tests"},
      {"@type": "MedicalTest", "name": "CA 19-9 blood test"},
      {"@type": "MedicalTest", "name": "Endoscopic ultrasound with biopsy"},
      {"@type": "MedicalTest", "name": "ERCP with biopsy"}
    ],
    "stage": [
      {"@type": "MedicalConditionStage", "stageAsNumber": 0, "subStageSuffix": "0", "name": "Stage 0 ‚Äî Carcinoma in situ"},
      {"@type": "MedicalConditionStage", "stageAsNumber": 1, "subStageSuffix": "I", "name": "Stage I ‚Äî Localized disease"},
      {"@type": "MedicalConditionStage", "stageAsNumber": 2, "subStageSuffix": "II", "name": "Stage II ‚Äî Regional involvement"},
      {"@type": "MedicalConditionStage", "stageAsNumber": 3, "subStageSuffix": "III", "name": "Stage III ‚Äî Lymph node involvement"},
      {"@type": "MedicalConditionStage", "stageAsNumber": 4, "subStageSuffix": "IV", "name": "Stage IV ‚Äî Distant metastasis"}
    ],
    "epidemiology": "Approximately 12,500 new cases diagnosed in the United States annually. Rare cancer, accounting for 3% of all GI cancers.",
    "isPartOf": {
      "@type": "WebSite",
      "name": "StopMyCancer",
      "url": "https://stopmycancer.com"
    }
  }
  </script>

  <!-- Structured Data ‚Äî Breadcrumb -->
  <script type="application/ld+json">
  {
    "@context": "https://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
      {
        "@type": "ListItem",
        "position": 1,
        "name": "Home",
        "item": "https://stopmycancer.com/"
      },
      {
        "@type": "ListItem",
        "position": 2,
        "name": "Cancer Types",
        "item": "https://stopmycancer.com/cancers/"
      },
      {
        "@type": "ListItem",
        "position": 3,
        "name": "Bile Duct Cancer",
        "item": "https://stopmycancer.com/cancers/bile-duct/"
      }
    ]
  }
  </script>

  <!-- Hreflang for multilingual SEO -->
  <link rel="alternate" hreflang="en" href="https://stopmycancer.com/cancers/bile-duct/">
  <link rel="alternate" hreflang="es" href="https://stopmycancer.com/es/cancers/bile-duct/">
  <link rel="alternate" hreflang="fr" href="https://stopmycancer.com/fr/cancers/bile-duct/">
  <link rel="alternate" hreflang="x-default" href="https://stopmycancer.com/cancers/bile-duct/">

  <!-- Preconnect & Fonts -->
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
  <link rel="preconnect" href="https://images.unsplash.com">

  <!-- Stylesheet -->
  <link rel="stylesheet" href="/css/styles.css">

  <!-- Favicon -->
  <link rel="icon" type="image/svg+xml" href="data:image/svg+xml,<svg xmlns='http://www.w3.org/2000/svg' viewBox='0 0 100 100'><text y='.9em' font-size='90'>üõ°Ô∏è</text></svg>">
</head>
<body>

  <!-- Skip Link -->
  <a href="#main" class="skip-link">Skip to main content</a>

  <!-- Header -->
  <header class="header" role="banner">
    <div class="header__inner">
      <a href="/" class="header__logo" aria-label="StopMyCancer Home">
        <div class="header__logo-icon" aria-hidden="true">S</div>
        Stop<span>My</span>Cancer
      </a>

      <nav class="header__nav" role="navigation" aria-label="Main navigation">
        <a href="/cancers/" class="header__nav-link header__nav-link--active">Cancer Types</a>
        <a href="/navigate/" class="header__nav-link">Navigate</a>
        <a href="/stories/" class="header__nav-link">Stories</a>
        <a href="/access/" class="header__nav-link">Access &amp; Equity</a>
        <a href="/tools/pathology-translator" class="header__nav-link">Translator Tool</a>
        <a href="/about/" class="header__nav-link">About</a>
      </nav>

      <div class="header__actions">
        <div class="lang-switcher">
          <button class="lang-switcher__btn" aria-haspopup="true" aria-expanded="false" aria-label="Change language">
            <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><circle cx="12" cy="12" r="10"></circle><line x1="2" y1="12" x2="22" y2="12"></line><path d="M12 2a15.3 15.3 0 0 1 4 10 15.3 15.3 0 0 1-4 10 15.3 15.3 0 0 1-4-10 15.3 15.3 0 0 1 4-10z"></path></svg>
            EN
            <svg width="12" height="12" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M6 9l6 6 6-6"></path></svg>
          </button>
          <div class="lang-switcher__dropdown" role="menu">
            <a href="/cancers/bile-duct/" class="lang-switcher__option lang-switcher__option--active" role="menuitem">English</a>
            <a href="/es/cancers/bile-duct/" class="lang-switcher__option" role="menuitem">Espa√±ol</a>
            <a href="/fr/cancers/bile-duct/" class="lang-switcher__option" role="menuitem">Fran√ßais</a>
          </div>
        </div>

        <button class="mobile-toggle" aria-label="Open menu" aria-expanded="false" aria-controls="mobile-nav">
          <span class="mobile-toggle__line"></span>
          <span class="mobile-toggle__line"></span>
          <span class="mobile-toggle__line"></span>
        </button>
      </div>
    </div>
  </header>

  <!-- Mobile Navigation -->
  <nav class="mobile-nav" id="mobile-nav" role="navigation" aria-label="Mobile navigation">
    <a href="/cancers/" class="mobile-nav__link">Cancer Types</a>
    <a href="/navigate/" class="mobile-nav__link">Navigate</a>
    <a href="/stories/" class="mobile-nav__link">Stories</a>
    <a href="/access/" class="mobile-nav__link">Access &amp; Equity</a>
    <a href="/tools/pathology-translator" class="mobile-nav__link">Pathology Translator</a>
    <a href="/about/" class="mobile-nav__link">About</a>
    <div class="mobile-nav__lang">
      <div class="mobile-nav__lang-title">Language</div>
      <div class="mobile-nav__lang-options">
        <a href="/cancers/bile-duct/" class="mobile-nav__lang-btn mobile-nav__lang-btn--active">EN</a>
        <a href="/es/cancers/bile-duct/" class="mobile-nav__lang-btn">ES</a>
        <a href="/fr/cancers/bile-duct/" class="mobile-nav__lang-btn">FR</a>
      </div>
    </div>
  </nav>

  <main id="main">

    <!-- ==================== BREADCRUMB ==================== -->
    <section class="section" style="padding-bottom: 0;">
      <div class="container">
        <nav class="breadcrumb fade-in" aria-label="Breadcrumb">
          <a href="/">Home</a>
          <span class="breadcrumb__sep" aria-hidden="true">/</span>
          <a href="/cancers/">Cancer Types</a>
          <span class="breadcrumb__sep" aria-hidden="true">/</span>
          <span aria-current="page">Bile Duct Cancer</span>
        </nav>
      </div>
    </section>

    <!-- ==================== PAGE HEADER ==================== -->
    <section class="page-header">
      <div class="container">
        <div class="fade-in">
          <span class="page-header__label">Medical Encyclopedia</span>
          <h1 class="page-header__title">Bile Duct Cancer (Cholangiocarcinoma)</h1>
          <p class="page-header__desc">
            A rare but serious cancer of the bile ducts. This guide explains types, risk factors, diagnosis, staging, treatment options including surgery and chemotherapy, and questions to ask your care team.
          </p>
        </div>
        <div class="page-header__image fade-in" style="transition-delay: 0.15s;">
          <img src="https://images.unsplash.com/photo-1576091160550-2173dba999ef?w=1200&h=400&fit=crop&q=80" alt="Medical researcher working in a clinical laboratory, representing evidence-based bile duct cancer research" loading="eager" width="1200" height="400">
        </div>
      </div>
    </section>

    <!-- ==================== SAFETY NOTICE ==================== -->
    <section class="section" style="padding-top: 0; padding-bottom: var(--space-xl);">
      <div class="container">
        <div class="safety-banner fade-in">
          <svg class="safety-banner__icon" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M10.29 3.86L1.82 18a2 2 0 0 0 1.71 3h16.94a2 2 0 0 0 1.71-3L13.71 3.86a2 2 0 0 0-3.42 0z"></path><line x1="12" y1="9" x2="12" y2="13"></line><line x1="12" y1="17" x2="12.01" y2="17"></line></svg>
          <div class="safety-banner__text">
            <strong>Not medical advice.</strong> StopMyCancer is an educational resource. It does not diagnose, predict outcomes, or replace your care team. If you experience severe symptoms ‚Äî persistent jaundice, severe abdominal pain, or fever ‚Äî <strong>seek immediate medical care</strong>.
          </div>
        </div>
      </div>
    </section>

    <!-- ==================== QUICK OVERVIEW ==================== -->
    <section class="section section--alt" id="overview">
      <div class="container">
        <div class="section__header fade-in">
          <span class="section__label">At a Glance</span>
          <h2 class="section__title">Quick Overview</h2>
        </div>
        <div class="card-grid fade-in" style="transition-delay: 0.1s;">
          <div class="card">
            <div class="card__body" style="text-align: center; padding: var(--space-2xl);">
              <div class="card__icon card__icon--primary" style="margin: 0 auto var(--space-md); font-size: 24px; width: 56px; height: 56px;">
                <span aria-hidden="true">~12K</span>
              </div>
              <h3 class="card__title">New Cases Per Year</h3>
              <p class="card__desc">Approximately 12,500 new cases diagnosed in the United States annually. Bile duct cancer accounts for about 3% of all gastrointestinal cancers. <a href="#references">[NCI, 2024]</a></p>
            </div>
          </div>
          <div class="card">
            <div class="card__body" style="text-align: center; padding: var(--space-2xl);">
              <div class="card__icon card__icon--secondary" style="margin: 0 auto var(--space-md); font-size: 24px; width: 56px; height: 56px;">
                <span aria-hidden="true">Rare</span>
              </div>
              <h3 class="card__title">Relatively Uncommon</h3>
              <p class="card__desc">Bile duct cancer is one of the rarer cancers, which means fewer treatment specialists but increasing clinical trial options. <a href="#references">[ACS, 2024]</a></p>
            </div>
          </div>
          <div class="card">
            <div class="card__body" style="text-align: center; padding: var(--space-2xl);">
              <div class="card__icon card__icon--accent" style="margin: 0 auto var(--space-md); font-size: 24px; width: 56px; height: 56px;">
                <span aria-hidden="true">Age 50+</span>
              </div>
              <h3 class="card__title">Typically Diagnosed in Older Adults</h3>
              <p class="card__desc">Median age at diagnosis is around 70 years. It is rarely diagnosed before age 40, though it can occur at any age. <a href="#references">[NCI, 2024]</a></p>
            </div>
          </div>
          <div class="card">
            <div class="card__body" style="text-align: center; padding: var(--space-2xl);">
              <div class="card__icon card__icon--info" style="margin: 0 auto var(--space-md); font-size: 24px; width: 56px; height: 56px;">
                <span aria-hidden="true">PSC</span>
              </div>
              <h3 class="card__title">Primary Sclerosing Cholangitis Risk</h3>
              <p class="card__desc">People with primary sclerosing cholangitis (PSC), a chronic bile duct condition, have a 400-fold increased risk of bile duct cancer. <a href="#references">[ACS, 2024]</a></p>
            </div>
          </div>
        </div>
      </div>
    </section>

    <!-- ==================== WHAT IS BILE DUCT CANCER ==================== -->
    <section class="section" id="what-is">
      <div class="container">
        <div class="section__header fade-in">
          <span class="section__label">Understanding the Basics</span>
          <h2 class="section__title">What Is Bile Duct Cancer?</h2>
        </div>
        <div class="prose fade-in" style="transition-delay: 0.1s;">
          <p>
            Bile duct cancer, medically known as cholangiocarcinoma, develops in the epithelial cells (the inner lining) of the bile ducts. The bile ducts are small tubes that carry bile ‚Äî a digestive liquid produced by the liver ‚Äî to the small intestine where it helps break down fats. When cancer develops, these tubes become narrow, blocking the flow of bile and causing a backup of bilirubin into the bloodstream, leading to jaundice (yellowing of the skin and eyes). <a href="#references">[NCI, 2024]</a>
          </p>
          <p>
            Bile duct cancer is divided into two main types based on location:
          </p>
          <ul>
            <li><strong>Intrahepatic cholangiocarcinoma</strong> ‚Äî arises inside the liver, accounts for about 10-15% of cases</li>
            <li><strong>Extrahepatic cholangiocarcinoma</strong> ‚Äî arises outside the liver (in the common bile duct or junction of bile ducts), accounts for about 85-90% of cases</li>
          </ul>
          <p>
            Bile duct cancer is often diagnosed at an advanced stage because early symptoms are minimal and the tumor can grow silently. This makes understanding your diagnosis, staging, and treatment options especially important for effective care.
          </p>
        </div>
      </div>
    </section>

    <!-- ==================== TYPES OF BILE DUCT CANCER ==================== -->
    <section class="section section--alt" id="types">
      <div class="container">
        <div class="section__header fade-in">
          <span class="section__label">Classification</span>
          <h2 class="section__title">Types of Bile Duct Cancer</h2>
          <p class="section__desc">The location and histologic subtype of bile duct cancer determine treatment strategy and prognosis.</p>
        </div>
        <div class="card-grid fade-in" style="transition-delay: 0.1s;">
          <div class="card">
            <div class="card__body" style="padding: var(--space-2xl);">
              <div class="card__icon card__icon--primary" style="margin-bottom: var(--space-md);">
                <span aria-hidden="true">In</span>
              </div>
              <h3 class="card__title">Intrahepatic Cholangiocarcinoma</h3>
              <p class="card__desc">
                Develops within the liver parenchyma (tissue) in the small bile ducts. Accounts for 10-15% of cholangiocarcinomas. Often presents as a solitary mass that may be confused with hepatocellular carcinoma. Treatment often involves hepatic resection (removal of part of the liver) or liver transplantation. <a href="#references">[ACS, 2024]</a>
              </p>
            </div>
          </div>
          <div class="card">
            <div class="card__body" style="padding: var(--space-2xl);">
              <div class="card__icon card__icon--secondary" style="margin-bottom: var(--space-md);">
                <span aria-hidden="true">Ex</span>
              </div>
              <h3 class="card__title">Extrahepatic Cholangiocarcinoma</h3>
              <p class="card__desc">
                Develops in the bile ducts outside the liver ‚Äî including the distal common bile duct, hepatic ducts, and junction of hepatic ducts. Accounts for 85-90% of cases. Presents with obstructive jaundice from the tumor blocking bile flow. Can often be resected surgically if detected early enough. <a href="#references">[NCI, 2024]</a>
              </p>
            </div>
          </div>
          <div class="card">
            <div class="card__body" style="padding: var(--space-2xl);">
              <div class="card__icon card__icon--accent" style="margin-bottom: var(--space-md);">
                <span aria-hidden="true">A</span>
              </div>
              <h3 class="card__title">Adenocarcinoma</h3>
              <p class="card__desc">
                The most common histologic type of bile duct cancer (90%+). Develops from glandular epithelial cells lining the bile ducts. Generally aggressive and has a variable prognosis depending on stage and degree of differentiation. <a href="#references">[ACS, 2024]</a>
              </p>
            </div>
          </div>
          <div class="card">
            <div class="card__body" style="padding: var(--space-2xl);">
              <div class="card__icon card__icon--info" style="margin-bottom: var(--space-md);">
                <span aria-hidden="true">S</span>
              </div>
              <h3 class="card__title">Squamous Cell &amp; Other Rare Types</h3>
              <p class="card__desc">
                Squamous cell carcinoma and mucinous carcinomas of the bile ducts are rare, accounting for less than 5% of cases. These have different biologic behaviors and may require specialized treatment approaches. Always discuss your specific histology with your oncology team. <a href="#references">[NCI, 2024]</a>
              </p>
            </div>
          </div>
        </div>
      </div>
    </section>

    <!-- ==================== RISK FACTORS ==================== -->
    <section class="section" id="risk-factors">
      <div class="container">
        <div class="section__header fade-in">
          <span class="section__label">Who Is at Risk</span>
          <h2 class="section__title">Risk Factors</h2>
          <p class="section__desc">Understanding your risk factors helps guide screening decisions and preventive measures when applicable.</p>
        </div>
        <div class="prose fade-in" style="transition-delay: 0.1s;">
          <h3>Primary Sclerosing Cholangitis (PSC)</h3>
          <p>
            The strongest risk factor for bile duct cancer. PSC is a chronic autoimmune disease causing progressive inflammation and scarring of the bile ducts. People with PSC have a 400-fold increased risk of cholangiocarcinoma. Regular screening and surveillance are recommended. <a href="#references">[ACS, 2024]</a>
          </p>

          <h3>Chronic Biliary Tract Infections</h3>
          <p>
            Chronic or recurrent infections, particularly from parasites like liver flukes (common in Southeast Asia), increase bile duct cancer risk. Bile duct stones and strictures (narrowing) that create stasis also increase risk by causing repeated inflammation. <a href="#references">[NCI, 2024]</a>
          </p>

          <h3>Cirrhosis &amp; Liver Disease</h3>
          <p>
            Cirrhosis from any cause (hepatitis B, hepatitis C, alcohol) increases bile duct cancer risk. The chronic inflammation and regeneration of liver tissue creates an environment favorable for malignant transformation. <a href="#references">[ACS, 2024]</a>
          </p>

          <h3>Choledochal Cysts</h3>
          <p>
            Congenital cysts of the bile ducts increase the risk of cholangiocarcinoma, with lifetime risk estimates of 5-20% depending on the cyst type. Prophylactic surgical resection is sometimes recommended. <a href="#references">[NCI, 2024]</a>
          </p>

          <h3>Inflammatory Bowel Disease</h3>
          <p>
            Patients with ulcerative colitis or Crohn's disease, especially those with concurrent PSC, have significantly increased bile duct cancer risk. Regular surveillance is recommended. <a href="#references">[ACS, 2024]</a>
          </p>

          <h3>Age &amp; Gender</h3>
          <p>
            Risk increases with age, with median diagnosis around 70 years. Men are slightly more likely to develop bile duct cancer than women. <a href="#references">[NCI, 2024]</a>
          </p>
        </div>
      </div>
    </section>

    <!-- ==================== SYMPTOMS ==================== -->
    <section class="section section--alt" id="symptoms">
      <div class="container">
        <div class="section__header fade-in">
          <span class="section__label">Know the Signs</span>
          <h2 class="section__title">Symptoms of Bile Duct Cancer</h2>
          <p class="section__desc">Early-stage bile duct cancer often causes no symptoms. When symptoms do appear, they typically relate to bile duct obstruction.</p>
        </div>
        <div class="checklist fade-in" style="transition-delay: 0.15s; max-width: 700px; margin-top: var(--space-xl);">
          <div class="checklist__item">
            <div class="checklist__icon">
              <svg width="12" height="12" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="3"><polyline points="20 6 9 17 4 12"></polyline></svg>
            </div>
            <span><strong>Jaundice</strong> ‚Äî yellowing of the skin and whites of the eyes, caused by bilirubin buildup</span>
          </div>
          <div class="checklist__item">
            <div class="checklist__icon">
              <svg width="12" height="12" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="3"><polyline points="20 6 9 17 4 12"></polyline></svg>
            </div>
            <span><strong>Itching (pruritus)</strong> ‚Äî often severe and persistent, worsened by jaundice</span>
          </div>
          <div class="checklist__item">
            <div class="checklist__icon">
              <svg width="12" height="12" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="3"><polyline points="20 6 9 17 4 12"></polyline></svg>
            </div>
            <span><strong>Pale or clay-colored stools</strong> ‚Äî from lack of bile reaching the intestines</span>
          </div>
          <div class="checklist__item">
            <div class="checklist__icon">
              <svg width="12" height="12" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="3"><polyline points="20 6 9 17 4 12"></polyline></svg>
            </div>
            <span><strong>Dark urine</strong> ‚Äî tea-colored or brown urine from bilirubin excretion</span>
          </div>
          <div class="checklist__item">
            <div class="checklist__icon">
              <svg width="12" height="12" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="3"><polyline points="20 6 9 17 4 12"></polyline></svg>
            </div>
            <span><strong>Abdominal pain</strong> ‚Äî in the upper right abdomen, may be dull or sharp</span>
          </div>
          <div class="checklist__item">
            <div class="checklist__icon">
              <svg width="12" height="12" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="3"><polyline points="20 6 9 17 4 12"></polyline></svg>
            </div>
            <span><strong>Nausea &amp; loss of appetite</strong> ‚Äî general digestive symptoms</span>
          </div>
          <div class="checklist__item">
            <div class="checklist__icon">
              <svg width="12" height="12" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="3"><polyline points="20 6 9 17 4 12"></polyline></svg>
            </div>
            <span><strong>Weight loss</strong> ‚Äî unintentional weight loss over weeks or months</span>
          </div>
        </div>
        <div class="prose fade-in" style="transition-delay: 0.2s; margin-top: var(--space-xl);">
          <div class="safety-banner">
            <svg class="safety-banner__icon" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M10.29 3.86L1.82 18a2 2 0 0 0 1.71 3h16.94a2 2 0 0 0 1.71-3L13.71 3.86a2 2 0 0 0-3.42 0z"></path><line x1="12" y1="9" x2="12" y2="13"></line><line x1="12" y1="17" x2="12.01" y2="17"></line></svg>
            <div class="safety-banner__text">
              <strong>Jaundice is a warning sign.</strong> If you develop jaundice, itching, pale stools, or dark urine lasting more than a few days, see your doctor promptly. Early detection can significantly affect treatment options and outcomes. <a href="#references">[NCI, 2024]</a>
            </div>
          </div>
        </div>
      </div>
    </section>

    <!-- ==================== DIAGNOSIS ==================== -->
    <section class="section" id="diagnosis">
      <div class="container">
        <div class="section__header fade-in">
          <span class="section__label">Finding the Answer</span>
          <h2 class="section__title">How Bile Duct Cancer Is Diagnosed</h2>
          <p class="section__desc">Diagnosis typically involves blood tests, imaging studies, and sometimes endoscopic tissue sampling.</p>
        </div>
        <div class="prose fade-in" style="transition-delay: 0.1s;">
          <h3>Blood Tests &amp; Liver Function</h3>
          <p>
            Initial blood work shows elevated bilirubin (conjugated), elevated liver enzymes (ALP, GGT, transaminases), and often elevated CA 19-9 (a tumor marker). These findings suggest bile duct obstruction but are not specific for cancer. <a href="#references">[ACS, 2024]</a>
          </p>

          <h3>Imaging: CT &amp; MRI/MRCP</h3>
          <p>
            High-resolution CT scans with contrast help visualize the tumor size, location, and extent of spread. MRI with magnetic resonance cholangiopancreatography (MRCP) provides detailed imaging of the bile ducts and can show the exact location of obstruction. These are the primary imaging modalities. <a href="#references">[NCI, 2024]</a>
          </p>

          <h3>Endoscopic Retrograde Cholangiopancreatography (ERCP)</h3>
          <p>
            An endoscopic procedure allowing direct visualization of the bile ducts and biopsy sampling. During ERCP, a stent (plastic tube) can also be placed to relieve biliary obstruction and allow bile drainage, providing symptomatic relief. <a href="#references">[ACS, 2024]</a>
          </p>

          <h3>Endoscopic Ultrasound (EUS)</h3>
          <p>
            High-resolution ultrasound performed via an endoscope allows close-up imaging of the bile ducts and precise biopsy sampling under real-time visualization. Often combines imaging with tissue diagnosis. <a href="#references">[NCI, 2024]</a>
          </p>

          <h3>Biopsy &amp; Pathology</h3>
          <p>
            Tissue diagnosis is essential. Brushings or biopsies obtained during ERCP or EUS are examined under a microscope to confirm adenocarcinoma and rule out benign strictures or other conditions. This is the definitive diagnosis. <a href="#references">[ACS, 2024]</a>
          </p>
        </div>
      </div>
    </section>

    <!-- ==================== STAGING ==================== -->
    <section class="section section--alt" id="staging">
      <div class="container">
        <div class="section__header fade-in">
          <span class="section__label">Tumor Extent</span>
          <h2 class="section__title">Staging System (TNM)</h2>
          <p class="section__desc">Bile duct cancer is staged using the TNM system. Staging determines treatment options and prognosis.</p>
        </div>
        <div class="card-grid fade-in" style="transition-delay: 0.1s; max-width: 1000px; margin: 0 auto;">
          <div class="card">
            <div class="card__body" style="padding: var(--space-2xl);">
              <div class="card__icon card__icon--primary" style="margin-bottom: var(--space-md); font-size: 20px;">
                <span aria-hidden="true">I</span>
              </div>
              <h3 class="card__title">Stage I ‚Äî Localized</h3>
              <p class="card__desc">
                Tumor confined to the bile duct without extension into surrounding tissues or involvement of major blood vessels. No lymph node involvement. These tumors are potentially resectable and carry the best prognosis. 5-year survival approximately 30-50%. <a href="#references">[ACS, 2024]</a>
              </p>
            </div>
          </div>
          <div class="card">
            <div class="card__body" style="padding: var(--space-2xl);">
              <div class="card__icon card__icon--secondary" style="margin-bottom: var(--space-md); font-size: 20px;">
                <span aria-hidden="true">II</span>
              </div>
              <h3 class="card__title">Stage II ‚Äî Regional Involvement</h3>
              <p class="card__desc">
                Tumor extends into surrounding tissues or involves major blood vessels, but without distant metastasis or distant lymph node involvement. May still be resectable depending on exact extent. 5-year survival approximately 15-30%. <a href="#references">[NCI, 2024]</a>
              </p>
            </div>
          </div>
          <div class="card">
            <div class="card__body" style="padding: var(--space-2xl);">
              <div class="card__icon card__icon--accent" style="margin-bottom: var(--space-md); font-size: 20px;">
                <span aria-hidden="true">III</span>
              </div>
              <h3 class="card__title">Stage III ‚Äî Regional Lymph Node Involvement</h3>
              <p class="card__desc">
                Cancer involves regional lymph nodes (regional nodes around the liver, pancreas, or bile ducts) regardless of whether the primary tumor is resectable. Distant metastasis is absent. Treatment often involves chemotherapy and palliative surgery. 5-year survival approximately 5-15%. <a href="#references">[ACS, 2024]</a>
              </p>
            </div>
          </div>
          <div class="card">
            <div class="card__body" style="padding: var(--space-2xl);">
              <div class="card__icon card__icon--info" style="margin-bottom: var(--space-md); font-size: 20px;">
                <span aria-hidden="true">IV</span>
              </div>
              <h3 class="card__title">Stage IV ‚Äî Distant Metastasis</h3>
              <p class="card__desc">
                Cancer has spread to distant organs (peritoneum, lungs, bone, brain) or distant lymph nodes. Typically not surgically resectable. Treatment focuses on chemotherapy and symptom management. 5-year survival less than 5%. <a href="#references">[NCI, 2024]</a>
              </p>
            </div>
          </div>
        </div>
      </div>
    </section>

    <!-- ==================== TREATMENT ==================== -->
    <section class="section" id="treatment">
      <div class="container">
        <div class="section__header fade-in">
          <span class="section__label">Your Options</span>
          <h2 class="section__title">Treatment for Bile Duct Cancer</h2>
          <p class="section__desc">Treatment depends on tumor stage, location, resectability, and overall health. Most patients benefit from multimodal therapy combining surgery, chemotherapy, and supportive care.</p>
        </div>
        <div class="prose fade-in" style="transition-delay: 0.1s;">

          <h3>Surgery: Resection &amp; Transplantation</h3>
          <p>
            Surgery offers the only potential cure for bile duct cancer. For extrahepatic tumors, the goal is resection (removal) of the tumor along with nearby lymph nodes and affected bile ducts. For intrahepatic tumors, hepatic resection (removal of part of the liver) may be performed. In select cases of early intrahepatic cholangiocarcinoma with underlying cirrhosis, liver transplantation may be considered. <a href="#references">[NCCN, 2024]</a>
          </p>

          <h3>Palliative Stenting</h3>
          <p>
            When the tumor cannot be surgically removed, a biliary stent (plastic or metal tube) is placed endoscopically or percutaneously to bypass the obstruction and allow bile drainage. This relieves jaundice and itching, improving quality of life. Stent patency (staying open) may require periodic replacement. <a href="#references">[ACS, 2024]</a>
          </p>

          <h3>Chemotherapy</h3>
          <p>
            The chemotherapy combination of gemcitabine and cisplatin is the standard first-line treatment for advanced bile duct cancer. Clinical trials have shown this combination improves survival in patients with unresectable or metastatic disease. Chemotherapy is typically given intravenously every 3-4 weeks for 6-8 cycles. <a href="#references">[NCCN, 2024]</a>
          </p>

          <h3>Radiation Therapy</h3>
          <p>
            External beam radiation or brachytherapy (internal radiation) may be used in select cases, either as primary treatment for unresectable disease or adjuvantly after surgery. Intensity-modulated radiation therapy (IMRT) minimizes damage to surrounding tissues. <a href="#references">[NCI, 2024]</a>
          </p>

          <h3>Targeted Therapy &amp; Immunotherapy</h3>
          <p>
            Research is advancing targeted therapies for specific mutations (FGFR2 fusions, IDH1 mutations) found in some bile duct cancers. Immunotherapy checkpoint inhibitors are being studied in clinical trials. These options may become standard as evidence accumulates. <a href="#references">[NCCN, 2024]</a>
          </p>

          <h3>Clinical Trials</h3>
          <p>
            Clinical trials investigating new drug combinations, targeted therapies, and immunotherapy approaches are critical resources for bile duct cancer patients. Discuss trial eligibility with your oncology team. Search <a href="https://clinicaltrials.gov" target="_blank" rel="noopener noreferrer">ClinicalTrials.gov</a> for current opportunities. <a href="#references">[NCI, 2024]</a>
          </p>
        </div>
      </div>
    </section>

    <!-- ==================== SIDE EFFECTS ==================== -->
    <section class="section section--alt" id="side-effects">
      <div class="container">
        <div class="section__header fade-in">
          <span class="section__label">What to Expect</span>
          <h2 class="section__title">Side Effects of Treatment</h2>
          <p class="section__desc">Cancer treatments have side effects. Knowing what to expect allows you and your care team to manage them proactively.</p>
        </div>
        <div class="card-grid fade-in" style="transition-delay: 0.1s;">
          <div class="card">
            <div class="card__body" style="padding: var(--space-2xl);">
              <h3 class="card__title">Surgical Side Effects</h3>
              <p class="card__desc">Pain at the incision site, infection risk, temporary bowel dysfunction, and possible need for permanent or temporary drainage tubes. Recovery typically takes 6-8 weeks.</p>
            </div>
          </div>
          <div class="card">
            <div class="card__body" style="padding: var(--space-2xl);">
              <h3 class="card__title">Chemotherapy Toxicity</h3>
              <p class="card__desc">Nausea, vomiting, fatigue, decreased blood cell counts (anemia, low white cells, low platelets), mouth sores, and diarrhea. Anti-nausea medications help manage these effects.</p>
            </div>
          </div>
          <div class="card">
            <div class="card__body" style="padding: var(--space-2xl);">
              <h3 class="card__title">Radiation Side Effects</h3>
              <p class="card__desc">Skin irritation, nausea, fatigue, and diarrhea during treatment. Potential for long-term effects on surrounding organs if extensive radiation is given.</p>
            </div>
          </div>
          <div class="card">
            <div class="card__body" style="padding: var(--space-2xl);">
              <h3 class="card__title">Stent Complications</h3>
              <p class="card__desc">Stent blockage, infection (cholangitis), or migration. Signs include fever, worsening jaundice, or abdominal pain ‚Äî report these immediately to your team.</p>
            </div>
          </div>
        </div>
      </div>
    </section>

    <!-- ==================== LIVING WITH BILE DUCT CANCER ==================== -->
    <section class="section" id="living-with">
      <div class="container">
        <div class="section__header fade-in">
          <span class="section__label">Beyond Treatment</span>
          <h2 class="section__title">Living With Bile Duct Cancer</h2>
          <p class="section__desc">Survivorship care, symptom management, and emotional support are integral parts of your cancer journey.</p>
        </div>
        <div class="prose fade-in" style="transition-delay: 0.1s;">

          <h3>Follow-Up Monitoring</h3>
          <p>
            After treatment, regular surveillance with CT or MRI imaging and CA 19-9 blood tests helps detect early recurrence. Most follow-up occurs every 2-3 months initially, then less frequently as you move further from treatment. <a href="#references">[NCCN, 2024]</a>
          </p>

          <h3>Nutritional Support</h3>
          <p>
            Bile duct cancer and its treatments can affect digestion and fat absorption. A registered dietitian can help optimize nutrition and manage diarrhea or other digestive symptoms. Fat-soluble vitamin supplementation may be needed. <a href="#references">[ACS, 2024]</a>
          </p>

          <h3>Mental Health &amp; Emotional Support</h3>
          <p>
            The diagnosis of a rare cancer can be emotionally overwhelming. Anxiety, depression, and fear of recurrence are common. Counseling, support groups, and psychiatric medications can help. Many cancer centers offer survivorship programs addressing psychological needs. <a href="#references">[NCI, 2024]</a>
          </p>

          <h3>Specialized Care Team</h3>
          <p>
            Because bile duct cancer is rare, consider seeking care at a comprehensive cancer center or center of excellence with significant experience in biliary cancers. Hepatobiliary surgeons and medical oncologists experienced in this disease provide optimized treatment. <a href="#references">[ACS, 2024]</a>
          </p>
        </div>
      </div>
    </section>

    <!-- ==================== QUESTIONS TO ASK ==================== -->
    <section class="section" id="questions">
      <div class="container">
        <div class="section__header fade-in">
          <span class="section__label">Be Prepared</span>
          <h2 class="section__title">Questions to Ask Your Care Team</h2>
          <p class="section__desc">Come prepared with questions about your diagnosis, treatment options, and supportive care.</p>
        </div>

        <div style="max-width: 800px; margin: 0 auto;">
          <div class="card fade-in" style="margin-bottom: var(--space-xl);">
            <div class="card__body" style="padding: var(--space-2xl);">
              <h3 class="card__title" style="margin-bottom: var(--space-lg);">About My Diagnosis</h3>
              <div class="checklist">
                <div class="checklist__item">
                  <div class="checklist__icon">
                    <svg width="12" height="12" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="3"><polyline points="20 6 9 17 4 12"></polyline></svg>
                  </div>
                  <span>Is my bile duct cancer intrahepatic or extrahepatic?</span>
                </div>
                <div class="checklist__item">
                  <div class="checklist__icon">
                    <svg width="12" height="12" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="3"><polyline points="20 6 9 17 4 12"></polyline></svg>
                  </div>
                  <span>What is my stage, and what does it mean for treatment and prognosis?</span>
                </div>
                <div class="checklist__item">
                  <div class="checklist__icon">
                    <svg width="12" height="12" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="3"><polyline points="20 6 9 17 4 12"></polyline></svg>
                  </div>
                  <span>Has genetic or molecular testing been performed on my tumor?</span>
                </div>
              </div>
            </div>
          </div>

          <div class="card fade-in" style="margin-bottom: var(--space-xl);">
            <div class="card__body" style="padding: var(--space-2xl);">
              <h3 class="card__title" style="margin-bottom: var(--space-lg);">About Treatment Options</h3>
              <div class="checklist">
                <div class="checklist__item">
                  <div class="checklist__icon">
                    <svg width="12" height="12" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="3"><polyline points="20 6 9 17 4 12"></polyline></svg>
                  </div>
                  <span>Am I a candidate for surgery? If not, why not?</span>
                </div>
                <div class="checklist__item">
                  <div class="checklist__icon">
                    <svg width="12" height="12" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="3"><polyline points="20 6 9 17 4 12"></polyline></svg>
                  </div>
                  <span>What chemotherapy regimen is recommended, and how long will treatment take?</span>
                </div>
                <div class="checklist__item">
                  <div class="checklist__icon">
                    <svg width="12" height="12" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="3"><polyline points="20 6 9 17 4 12"></polyline></svg>
                  </div>
                  <span>Are there clinical trials I should consider?</span>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </section>

    <!-- ==================== SOURCES & REFERENCES ==================== -->
    <section class="section section--alt" id="references">
      <div class="container">
        <div class="section__header fade-in">
          <span class="section__label">Evidence Base</span>
          <h2 class="section__title">Sources &amp; References</h2>
          <p class="section__desc">Every claim on this page is grounded in clinical guidelines and peer-reviewed research.</p>
        </div>
        <div class="prose fade-in" style="transition-delay: 0.1s;">
          <ol>
            <li>
              <strong>American Cancer Society (ACS).</strong> "Bile Duct Cancer Overview." Cancer.org. Accessed 2024.
              <br><a href="https://www.cancer.org/cancer/bile-duct-cancer.html" target="_blank" rel="noopener noreferrer">https://www.cancer.org/cancer/bile-duct-cancer.html</a>
            </li>
            <li>
              <strong>National Cancer Institute (NCI).</strong> "Bile Duct Cancer Treatment (PDQ) ‚Äî Patient Version." Cancer.gov. Accessed 2024.
              <br><a href="https://www.cancer.gov/types/bile-duct" target="_blank" rel="noopener noreferrer">https://www.cancer.gov/types/bile-duct</a>
            </li>
            <li>
              <strong>National Comprehensive Cancer Network (NCCN).</strong> "NCCN Clinical Practice Guidelines in Oncology: Bile Duct and Hepatocellular Carcinoma." Version 1.2024.
              <br><a href="https://www.nccn.org/guidelines/" target="_blank" rel="noopener noreferrer">https://www.nccn.org/guidelines/</a>
            </li>
            <li>
              <strong>World Health Organization (WHO).</strong> "Cholangiocarcinoma." WHO Global Cancer Observatory. Accessed 2024.
              <br><a href="https://gco.iarc.fr/" target="_blank" rel="noopener noreferrer">https://gco.iarc.fr/</a>
            </li>
          </ol>
          <p style="margin-top: var(--space-xl); color: var(--color-text-muted); font-size: var(--text-sm);">
            <strong>Last reviewed:</strong> February 2025. This page is regularly reviewed and updated as new evidence becomes available. StopMyCancer is not affiliated with any of the organizations cited above.
          </p>
        </div>
      </div>
    </section>

    <!-- ==================== CTA BANNER ==================== -->
    <section class="section">
      <div class="container">
        <div class="cta-banner fade-in">
          <h2>Understand Your Pathology Report</h2>
          <p>Paste your bile duct cancer pathology report and get plain-language explanations of every term, stage, and finding. Free, private, and evidence-based.</p>
          <a href="/tools/pathology-translator" class="btn btn--accent btn--lg">
            <svg width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M14 2H6a2 2 0 0 0-2 2v16a2 2 0 0 0 2 2h12a2 2 0 0 0 2-2V8z"></path><polyline points="14 2 14 8 20 8"></polyline><line x1="16" y1="13" x2="8" y2="13"></line><line x1="16" y1="17" x2="8" y2="17"></line></svg>
            Translate My Pathology Report
          </a>
        </div>
      </div>
    </section>

  </main>

  <!-- ==================== FOOTER ==================== -->
  <footer class="footer" role="contentinfo">
    <div class="container">
      <div class="footer__grid">
        <div class="footer__brand">
          <div class="footer__logo">Stop<span>My</span>Cancer</div>
          <p class="footer__tagline">Your cancer. Explained. Supported. Navigated. A clinically-grounded, plain-language cancer guide. Free, global, and female-first.</p>
        </div>
        <div>
          <h4 class="footer__col-title">Learn</h4>
          <a href="/cancers/" class="footer__link">Cancer Types</a>
          <a href="/navigate/" class="footer__link">Navigation Guides</a>
          <a href="/stories/" class="footer__link">Stories</a>
          <a href="/access/" class="footer__link">Access &amp; Equity</a>
        </div>
        <div>
          <h4 class="footer__col-title">Tools</h4>
          <a href="/tools/pathology-translator" class="footer__link">Pathology Translator</a>
          <a href="/navigate/questions-to-ask" class="footer__link">Questions to Ask</a>
          <a href="/navigate/second-opinion" class="footer__link">Second Opinion Guide</a>
        </div>
        <div>
          <h4 class="footer__col-title">About</h4>
          <a href="/about/" class="footer__link">Our Mission</a>
          <a href="/about/#evidence" class="footer__link">Evidence Standards</a>
          <a href="/about/#safety" class="footer__link">Safety Framework</a>
        </div>
      </div>
      <div class="footer__bottom">
        <p class="footer__copyright">&copy; 2025 StopMyCancer.com. Not medical advice. Educational resource only. Always consult your care team.</p>
        <div class="footer__legal">
          <a href="/es/" class="footer__legal-link">Espa√±ol</a>
          <a href="/fr/" class="footer__legal-link">Fran√ßais</a>
        </div>
      </div>
    </div>
  </footer>

  <!-- Scripts -->
  <script src="/js/main.js"></script>
</body>
</html>
